Dear Doctor: What is high-output heart failure, and how is it treated?
ANSWER: Heart failure is simply when the heart is unable to pump all the blood it needs to meet the body’s demands. Heart ...
Dr. Roach: Embolization provides great benefit to man with heart failure
The EF is normally 50% to 75%, so heart failure with an EF of less than 50% is heart failure with reduced ejection fraction ...
The Marshall News Messenger5d
To Your Good Health: Embolization provides great benefit to man with heart failure
My husband is 73 and was diagnosed with heart failure and a severely dilated left ventricle. At the time, he was pumping 10 ...
Opinion
Sun Journal6dOpinion
Embolization provides great benefit to man with heart failure
My husband is 73 and was diagnosed with heart failure and a severely dilated left ventricle. At the time, he was pumping 10 liters per minute. He had a proBNP natriuretic peptide level over 10,000 and ...
Daily4d
Finerenone Proven Effective in Reducing Heart Failure Events Across Genders in FINEARTS-HF Trial
UK: In a secondary analysis of the FINEARTS-HF randomized clinical trial, researchers found that finerenone, a novel ...
Daily6d
Old Delhi’s First CRT-D Procedure Successfully Performed at Sanjeevan Hospital
Delhi: Sanjeevan Hospital, located on Ansari Road, Darya Ganj, New Delhi, has achieved a remarkable milestone by becoming the ...
Joplin Globe2d
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer ...
Medscape5d
Pharmacologic Management of Heart Failure with Preserved Ejection Fraction
The study enrolled 4128 patients 60 years and older with NYHA class II-IV symptoms and ejection fraction ≥45% who were hospitalized for heart failure during the last 6 months or had persistent ...
Armed robbery in Revesby2d
FDA Greenlights Pfizer Combo for Metastatic Colorectal Cancer
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) in combination with ...
The American Journal of Managed Care2d
Weight Loss Drug Tirzepatide Now Approved for Sleep Apnea in Adults With Obesity
The approval was based on the results of the SURMOUNT-OSA trial, which found patients had fewer breathing disruptions.
Cytokinetics Announces Sanofi Acquired Rights To Develop And Commercialize Aficamten In Greater China
CORXEL (formerly Ji Xing) acquired the rights to develop and commercialize aficamten in Greater China (including the Chinese mainland, Hong Kong SAR and Macau SAR, and Taiwan) from Cytokinetics in ...